文献速递免疫规划

表达IBDV VP2-2C3d融合蛋白的转基因堆型艾美耳球虫的免疫原性及对传染性法氏囊病的保护作用

Immunogenicity and protection against infectious bursal disease via a transgenic Eimeria acervulina expressing IBDV VP2-2C3d fusion protein.
PubMed 文献 · Vaccine · 2025-09-09

研究将密码子优化的IBDV VP2与3C3d序列整合入堆型艾美耳球虫基因组,获得表达VP2融合C3d的转基因虫株Ea-2C3d;该虫株诱导的抗VP2抗体滴度显著高于亲本Ea-VP2株(P < 0.05),攻毒后法氏囊病变减轻(组织病理评分≤1)且法氏囊指数>0.7,与商业亚单位疫苗相当;转基因虫株繁殖能力下降但仍保持免疫原性和安全性。

要点

  • Ea-2C3d诱导的抗VP2抗体滴度显著高于亲本Ea-VP2株(P < 0.05),尤其在第二次免疫后。
  • 攻毒后Ea-2C3d免疫鸡法氏囊组织病理评分≤1、法氏囊指数>0.7,与商业亚单位疫苗相当。
  • 转基因虫株繁殖能力下降,但仍保持免疫原性和安全性。

核心结论

  • C3d佐剂增强了以球虫为载体的VP2介导的保护,提供了一种针对传染性法氏囊病和球虫病的双重保护新策略。

研究设计与样本

  • 利用限制性内切酶介导转染将密码子优化的VP2与3C3d序列整合入堆型艾美耳球虫基因组,构建转基因株Ea-2C3d。
  • 通过PCR、蛋白检测和基因组测序确认VP2融合C3d的整合与表达。
  • 开展体内研究比较Ea-2C3d与亲本Ea-VP2株的免疫原性,并以强毒IBDV攻毒评估保护效果。

主要发现

  • Ea-2C3d诱导的抗VP2抗体滴度显著高于亲本Ea-VP2株(P < 0.05),尤其在第二次免疫后。
  • 攻毒后Ea-2C3d免疫鸡法氏囊病变减轻(组织病理评分≤1)且法氏囊完整性维持(法氏囊指数>0.7),与商业亚单位疫苗相当。
  • 转染过程中一个C3d拷贝发生部分缺失,仅两个C3d拷贝成功表达。
  • 转基因寄生虫繁殖能力下降,但仍保持免疫原性和安全性。

局限性

  • 转染过程中一个C3d拷贝发生部分缺失,仅两个C3d拷贝成功表达。
  • 转基因寄生虫繁殖能力下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infectious bursal disease (IBD), caused by the infectious bursal disease virus (IBDV), significantly threatens global poultry health by inducing immunosuppression and causing economic losses. To enhance vaccination efficacy, we engineered a transgenic strain of Eimeria acervulina (Ea-2C3d) expressing a fusion protein composed of IBDV VP2 and three tandem C3d segments (3C3d), utilizing C3d's adjuvant properties to boost immune responses. The transgene was generated by integrating codon-optimized VP2 and 3C3d sequences into the E. acervulina genome using restriction enzyme-mediated transfection. PCR, protein, and genome sequencing confirmed the successful integration and expression of VP2 fusion C3d, but only two copies of C3d were successfully expressed, due to a partial deletion of one C3d copy during the transfection process. In vivo studies demonstrated that Ea-2C3d elicited significantly higher anti-VP2 antibody titers than the parental Ea-VP2 strain (P < 0.05), especially following second immunization. Upon challenge with virulent IBDV, chickens immunized with Ea-2C3d displayed reduced bursal lesions (histopathological score ≤ 1) and maintained bursal integrity (bursal index >0.7), comparable to those receiving a commercial subunit vaccine. Despite reduced reproductive capacity in the transgenic parasites, Ea-2C3d maintained its immunogenicity and safety. These findings highlight that C3d adjuvant enhances VP2-mediated protection in a coccidial vector, presenting a novel dual-protection strategy against IBD and coccidiosis.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sun Y, Liu Y, Wang H, et al. Immunogenicity and protection against infectious bursal disease via a transgenic Eimeria acervulina expressing IBDV VP2-2C3d fusion protein. Vaccine. 2025. PMID: 40930043. doi:10.1016/j.vaccine.2025.127715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。